1-8 of 8
Jeroen C. J. Eikenboom
Close
Sort by
Journal Articles

Biogenesis and Exocytosis of Weibel-Palade Bodies Is Affected by Naturally Occurring Von Willebrand Disease Variants within the A1-A3 Domains of VWF

Dafna J Groeneveld, Msc, Jiong-Wei Wang, Msc, Marjon J Mourik, Msc, Richard J Dirven, Bsc, Karine M Valentijn, PhD, Jan Voorberg, PhD, Pieter H. Reitsma, PhD, Jeroen C. J. Eikenboom, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1072.
https://doi.org/10.1182/blood.V120.21.1072.1072
Published: 2012
Journal Articles

Imaging of Von Willebrand Factor Remodeling Upon Secretion From Vascular Endothelial Cells

Marjon J Mourik, Msc, Karine M Valentijn, PhD, Jack A Valentijn, PhD, Jan Voorberg, PhD, Abraham J Koster, PhD, Jeroen C. J. Eikenboom, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 263.
https://doi.org/10.1182/blood.V120.21.263.263
Published: 2012
Journal Articles

Intracellular Retention, Enhanced Clearance, and Defective FVIII Binding Are Common Features of Von Willebrand Factor D'-D3 Domain Mutations in Patients with Von Willebrand Disease Type 1 From the European Mcmdm-1VWD Study

Reinhard Schneppenheim, MD, PhD, Ulrich Budde, MD, Javier Batlle, MD, Giancarlo Castaman, MD, Jeroen C. J. Eikenboom, MD, PhD, Augusto B. Federici, MD, Jenny Goudemand, MD, PhD, Tobias Obser, Florian Oyen, Francesco Rodeghiero, MD, Sonja Schneppenheim, MD, Ian R. Peake, PhD, Anne C. Goodeve, PhD
Journal: Blood
Blood (2012) 120 (21): 99.
https://doi.org/10.1182/blood.V120.21.99.99
Published: 2012
Journal Articles

Factor VIII alters tubular organization and functional properties of von Willebrand factor stored in Weibel-Palade bodies

Eveline A. M. Bouwens, Marjon J. Mourik, Maartje van den Biggelaar, Jeroen C. J. Eikenboom, Jan Voorberg, Karine M. Valentijn, Koen Mertens
Journal: Blood
Blood (2011) 118 (22): 5947–5956.
https://doi.org/10.1182/blood-2011-05-355354
Published: 2011
Includes: Multimedia, Supplemental data
Journal Articles

Investigation of the Role of Copy Number Variation In the Pathogenesis of Type 1 Von Willebrand Disease

Daniel J. Hampshire, PhD, Lisa D. Bloomer, MSc, Ahlam M. Al-Buhairan, PhD, Rachael E. Coyle, Raymon N. C. P. Vijzelaar, MSc, David Lillicrap, MD, Paula D. James, MD, Jeroen C. J. Eikenboom, MD, PhD, Reinhard Schneppenheim, MD, PhD, Francesco Rodeghiero, MD, Robert R. Montgomery, MD, Ian R. Peake, PhD, Anne C. Goodeve, PhD
Journal: Blood
Blood (2010) 116 (21): 2218.
https://doi.org/10.1182/blood.V116.21.2218.2218
Published: 2010
Journal Articles

Variations in glycosylation of von Willebrand factor with O -linked sialylated T antigen are associated with its plasma levels

Carina J. M. van Schooten, Cécile V. Denis, Ton Lisman, Jeroen C. J. Eikenboom, Frank W. Leebeek, Jenny Goudemand, Edith Fressinaud, H. Marijke van den Berg, Philip G. de Groot, Peter J. Lenting
Journal: Blood
Blood (2006) 109 (6): 2430–2437.
https://doi.org/10.1182/blood-2006-06-032706
Published: 2006
Journal Articles

ABO blood group also influences the von Willebrand factor (VWF) antigen level in heterozygous carriers of VWF null alleles, type 2N mutation Arg854Gln, and the missense mutation Cys2362Phe

Giancarlo Castaman, Jeroen C. J. Eikenboom
Journal: Blood
Blood (2002) 100 (5): 1927–1928.
https://doi.org/10.1182/blood-2002-04-1168
Published: 2002
Journal Articles

Type 1 von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers: a possible general mechanism for dominant mutations of oligomeric proteins

Imre Bodó, Akira Katsumi, Elodee A. Tuley, Jeroen C. J. Eikenboom, Zhengyu Dong, J. Evan Sadler
Journal: Blood
Blood (2001) 98 (10): 2973–2979.
https://doi.org/10.1182/blood.V98.10.2973
Published: 2001